Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Clinical trial NCT07085039 · RECRUITING

Trial details

NCT number: NCT07085039
Sponsor: University of Pennsylvania
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castleman's Disease (CD)Idiopathic Multicentric Castleman's Disease

Start date: 2025-12-18
Primary completion: 2028-07-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.